Prospects of anti-GD2 immunotherapy for retinoblastoma.
Saved in:
| Title: | Prospects of anti-GD2 immunotherapy for retinoblastoma. |
|---|---|
| Authors: | Zhang X; Affiliated Hospital of Shandong Second Medical University,School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.; Jinming Yu Academician Workstation of Oncology, Shandong Second Medical University, Shandong, China.; School of Clinical Medicine, Shandong Second Medical University, Weifang, China., You W; Department of Orthopedics, Wuxi Hospital Affiliated of Nanjing University of Chinese Medicine, Wuxi, China.; Medical Center, University of Chicago, Chicago, IL, United States., Wang Y; Affiliated Hospital of Shandong Second Medical University,School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.; Jinming Yu Academician Workstation of Oncology, Shandong Second Medical University, Shandong, China.; School of Clinical Medicine, Shandong Second Medical University, Weifang, China., Dejenie R; Medical Center, University of Chicago, Chicago, IL, United States.; School of Medicine, University of California, Davis, Davis, CA, United States., Wang C; Department of Orthopedics, Wuxi Hospital Affiliated of Nanjing University of Chinese Medicine, Wuxi, China., Huang Y; Affiliated Hospital of Shandong Second Medical University,School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.; Jinming Yu Academician Workstation of Oncology, Shandong Second Medical University, Shandong, China.; School of Clinical Medicine, Shandong Second Medical University, Weifang, China., Li J; Affiliated Hospital of Shandong Second Medical University,School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.; Jinming Yu Academician Workstation of Oncology, Shandong Second Medical University, Shandong, China.; School of Clinical Medicine, Shandong Second Medical University, Weifang, China.; Medical Center, University of Chicago, Chicago, IL, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Nov 15; Vol. 15, pp. 1499700. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1499700 |
